Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
doi: 10.1038/s41598-017-08799-w 53 HeinlS.HartingerD.ThamheslM.SchatzmayrG.MollW
Abstract Cancer remains the leading cause of death worldwide
Your provider can recommend other things to avoid during your appointment.
Phase l dose escalation and expansion of ziftomenib in combination with quizartinib in AML
ZhongMKawaguchiRCostabileBTangYHuJChengGet al
Sourav Mohanto would like to acknowledge Yenepoya (Deemed to be University), India for providing the research facilities to draft this manuscript
US$ 24.46
US$ 24.87
US$ 26.96
US$ 29.23
US$ 27.37
US$ 20.94
US$ 21.96
US$ 29.95
US$ 24.34
US$ 23.65
.webp)
US$ 21.65
US$ 29.30
US$ 23.51
![[engel-26138] 3696](https://cdn.shopify.com/s/files/1/0903/8521/9915/files/1_20250517_163427_0000_7483e691-8f4a-4aa8-a53d-248d8a7e318b.png?v=1784942051)
